Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

NWBO

Northwest Biotherapeutics, Inc.

Healthcare · USD

Set alert

Price alert · NWBO

All alert types
0.17 USD 0.00 0.00%
As of Oct 30, 2026
0.166 Day range 0.1774
0.15 52-week range 0.32
YTD
-26.09%
1 year
-29.17%
Open
0.17
Prev close
0.17
Mkt cap
289.96M
Vol
1.11M
Avg vol
4.07M
EPS
-0.03
P/E
0.00
Div yield
0.00%
More statistics
Low
0.166
High
0.1774
Forward P/E
0.00
Beta
0.55
Short ratio
13.54
Inst. own
42.60%
Dividend
0.00
Ex-div date
50-d avg
0.407273
200-d avg
0.457338
1y target
5.00

5D chart

Chart tools
Interval
1m5m15m30m
NWBO five-day price chart0.150.150.160.160.17Oct 23Oct 26Oct 27Oct 28Oct 29

Financial health

Altman Z-Score

-30.10 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -5.4×
FY 2016: -0.5×FY 2017: -0.8×FY 2018: -1.8×FY 2019: -5.3×FY 2020: -2.1×FY 2021: 3.3×FY 2022: -7.8×FY 2023: -12.3×FY 2024: -3.9×FY 2025: -5.4×
FY 2016 5y median -5.4× FY 2025
P/S 240×
FY 2016: 62.4×FY 2017: 173×FY 2018: 224×FY 2019: 49.2×FY 2020: 859×FY 2021: 608×FY 2022: 474×FY 2023: 409×FY 2024: 243×FY 2025: 240×
FY 2016 5y median 409× FY 2025
P/B -7.0×
FY 2016: -1.5×FY 2017: -1.2×FY 2018: -2.0×FY 2019: -2.7×FY 2020: -3.1×FY 2021: -4.9×FY 2022: -6.2×FY 2023: -16.8×FY 2024: -4.2×FY 2025: -7.0×
FY 2016 5y median -6.2× FY 2025
P/FCF -7.2×
FY 2016: -0.6×FY 2017: -1.6×FY 2018: -2.7×FY 2019: -3.7×FY 2020: -28.7×FY 2021: -13.8×FY 2022: -14.3×FY 2023: -13.8×FY 2024: -5.8×FY 2025: -7.2×
FY 2016 5y median -13.8× FY 2025
EV/EBITDA -7.9×
FY 2016: -0.8×FY 2017: -1.3×FY 2018: -3.5×FY 2019: -7.7×FY 2020: -2.1×FY 2021: 3.4×FY 2022: -8.4×FY 2023: -15.1×FY 2024: -5.4×FY 2025: -7.9×
FY 2016 5y median -7.9× FY 2025
EV/Sales 285×
FY 2016: 103×FY 2017: 267×FY 2018: 211×FY 2019: 56.7×FY 2020: 867×FY 2021: 631×FY 2022: 485×FY 2023: 431×FY 2024: 290×FY 2025: 285×
FY 2016 5y median 431× FY 2025
FCF Yield -14.0%
FY 2016: -155.9%FY 2017: -62.6%FY 2018: -37.6%FY 2019: -27.2%FY 2020: -3.5%FY 2021: -7.2%FY 2022: -7.0%FY 2023: -7.2%FY 2024: -17.3%FY 2025: -14.0%
FY 2016 5y median -7.2% FY 2025

Profitability

Gross Margin -69.6%
FY 2016: -9543.8%FY 2017: -9874.7%FY 2018: -4306.3%FY 2019: -485.3%FY 2020: -2505.5%FY 2021: -1920.7%FY 2022: 8.0%FY 2023: -1335.3%FY 2024: 100.0%FY 2025: -69.6%
FY 2016 5y median -69.6% FY 2025
Operating Margin -4347.9%
FY 2016: -12723.3%FY 2017: -16273.2%FY 2018: -10068.2%FY 2019: -1139.5%FY 2020: -6708.4%FY 2021: -5244.0%FY 2022: -3991.7%FY 2023: -2873.1%FY 2024: -4812.4%FY 2025: -4347.9%
FY 2016 5y median -4347.9% FY 2025
Net Margin -4461.3%
FY 2016: -12875.4%FY 2017: -21768.8%FY 2018: -8687.9%FY 2019: -863.6%FY 2020: -41039.6%FY 2021: 17823.5%FY 2022: -6240.8%FY 2023: -3240.1%FY 2024: -6062.1%FY 2025: -4461.3%
FY 2016 5y median -4461.3% FY 2025
ROE 129.2%
FY 2016: 302.7%FY 2017: 154.7%FY 2018: 75.9%FY 2019: 47.8%FY 2020: 146.0%FY 2021: -144.5%FY 2022: 82.0%FY 2023: 133.3%FY 2024: 106.1%FY 2025: 129.2%
FY 2016 5y median 106.1% FY 2025
ROIC -186.5%
FY 2016: -1520.8%FY 2017: 344.7%FY 2018: 136.6%FY 2019: 109.2%FY 2020: 25.3%FY 2021: 61.5%FY 2022: 85.7%FY 2023: -1606.6%FY 2024: 972.3%FY 2025: -186.5%
FY 2016 5y median 61.5% FY 2025
ROA -75.6%
FY 2016: -151.6%FY 2017: -149.6%FY 2018: -145.1%FY 2019: -228.0%FY 2020: -1610.4%FY 2021: 446.0%FY 2022: -335.3%FY 2023: -224.7%FY 2024: -313.4%FY 2025: -75.6%
FY 2016 5y median -224.7% FY 2025

Growth (YoY)

Revenue -0.3%
FY 2016: -64.2%FY 2017: -46.1%FY 2018: 22.6%FY 2019: 485.0%FY 2020: -46.4%FY 2021: -22.2%FY 2022: 67.5%FY 2023: 14.8%FY 2024: -28.5%FY 2025: -0.3%
FY 2016 FY 2025
Operating Income 9.9%
FY 2016: 37.2%FY 2017: 31.0%FY 2018: 24.1%FY 2019: 33.8%FY 2020: -215.4%FY 2021: 39.1%FY 2022: -27.5%FY 2023: 17.4%FY 2024: -19.8%FY 2025: 9.9%
FY 2016 FY 2025
EPS (diluted) 38.5%
FY 2016: 48.0%FY 2017: 59.7%FY 2018: 61.3%FY 2019: 66.7%FY 2020: -1725.0%FY 2021: 124.7%FY 2022: -155.6%FY 2023: 40.0%FY 2024: -14.3%FY 2025: 38.5%
FY 2016 FY 2025
Free Cash Flow 20.3%
FY 2016: 29.0%FY 2017: 39.8%FY 2018: 4.7%FY 2019: 7.4%FY 2020: -20.1%FY 2021: -14.5%FY 2022: -25.6%FY 2023: -2.5%FY 2024: -1.7%FY 2025: 20.3%
FY 2016 FY 2025

Financial Health

Current Ratio 0.1×
FY 2016: 0.1×FY 2017: 0.0×FY 2018: 0.3×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
Quick Ratio 0.1×
FY 2016: 0.1×FY 2017: 0.0×FY 2018: 0.3×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
Debt / Equity -1.4×
FY 2016: -1.2×FY 2017: -0.7×FY 2018: -0.4×FY 2019: -0.4×FY 2020: -0.1×FY 2021: -0.3×FY 2022: -0.2×FY 2023: -1.0×FY 2024: -0.9×FY 2025: -1.4×
FY 2016 5y median -0.9× FY 2025
Net Debt / EBITDA -1.2×
FY 2016: -0.3×FY 2017: -0.5×FY 2018: 0.2×FY 2019: -1.0×FY 2020: -0.0×FY 2021: 0.1×FY 2022: -0.2×FY 2023: -0.8×FY 2024: -0.9×FY 2025: -1.2×
FY 2016 5y median -0.8× FY 2025
Interest Coverage 6.9×
FY 2016: -20.8×FY 2017: -9.9×FY 2018: -4.2×FY 2019: -9.2×FY 2020: -10.1×FY 2021: -10.5×FY 2022: -11.1×FY 2023: -10.6×FY 2024: -8.6×FY 2025: 6.9×
FY 2016 5y median -10.5× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31